These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 15178558)

  • 1. Lysosomal cysteine proteases in atherosclerosis.
    Liu J; Sukhova GK; Sun JS; Xu WH; Libby P; Shi GP
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1359-66. PubMed ID: 15178558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice.
    Sukhova GK; Wang B; Libby P; Pan JH; Zhang Y; Grubb A; Fang K; Chapman HA; Shi GP
    Circ Res; 2005 Feb; 96(3):368-75. PubMed ID: 15653570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do cathepsins play a role in abdominal aortic aneurysm pathogenesis?
    Sukhova GK; Shi GP
    Ann N Y Acad Sci; 2006 Nov; 1085():161-9. PubMed ID: 17182932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications.
    Cheng XW; Huang Z; Kuzuya M; Okumura K; Murohara T
    Hypertension; 2011 Dec; 58(6):978-86. PubMed ID: 21986502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries.
    Cheng XW; Kuzuya M; Sasaki T; Arakawa K; Kanda S; Sumi D; Koike T; Maeda K; Tamaya-Mori N; Shi GP; Saito N; Iguchi A
    Am J Pathol; 2004 Jan; 164(1):243-51. PubMed ID: 14695337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.
    Kitamoto S; Sukhova GK; Sun J; Yang M; Libby P; Love V; Duramad P; Sun C; Zhang Y; Yang X; Peters C; Shi GP
    Circulation; 2007 Apr; 115(15):2065-75. PubMed ID: 17404153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Pan JH; Sukhova GK; Yang JT; Wang B; Xie T; Fu H; Zhang Y; Satoskar AR; David JR; Metz CN; Bucala R; Fang K; Simon DI; Chapman HA; Libby P; Shi GP
    Circulation; 2004 Jun; 109(25):3149-53. PubMed ID: 15197138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.
    de Nooijer R; Bot I; von der Thüsen JH; Leeuwenburgh MA; Overkleeft HS; Kraaijeveld AO; Dorland R; van Santbrink PJ; van Heiningen SH; Westra MM; Kovanen PT; Jukema JW; van der Wall EE; van Berkel TJ; Shi GP; Biessen EA
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):188-94. PubMed ID: 19095996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit.
    Burns-Kurtis CL; Olzinski AR; Needle S; Fox JH; Capper EA; Kelly FM; McQueney MS; Romanic AM
    Cardiovasc Res; 2004 Jun; 62(3):610-20. PubMed ID: 15158154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice.
    Jormsjö S; Wuttge DM; Sirsjö A; Whatling C; Hamsten A; Stemme S; Eriksson P
    Am J Pathol; 2002 Sep; 161(3):939-45. PubMed ID: 12213722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C deficiency in human atherosclerosis and aortic aneurysms.
    Shi GP; Sukhova GK; Grubb A; Ducharme A; Rhode LH; Lee RT; Ridker PM; Libby P; Chapman HA
    J Clin Invest; 1999 Nov; 104(9):1191-7. PubMed ID: 10545518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.
    Sukhova GK; Shi GP; Simon DI; Chapman HA; Libby P
    J Clin Invest; 1998 Aug; 102(3):576-83. PubMed ID: 9691094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.
    Lutgens E; Lutgens SP; Faber BC; Heeneman S; Gijbels MM; de Winther MP; Frederik P; van der Made I; Daugherty A; Sijbers AM; Fisher A; Long CJ; Saftig P; Black D; Daemen MJ; Cleutjens KB
    Circulation; 2006 Jan; 113(1):98-107. PubMed ID: 16365196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of the cysteine protease cathepsin S impairs microvessel growth.
    Shi GP; Sukhova GK; Kuzuya M; Ye Q; Du J; Zhang Y; Pan JH; Lu ML; Cheng XW; Iguchi A; Perrey S; Lee AM; Chapman HA; Libby P
    Circ Res; 2003 Mar; 92(5):493-500. PubMed ID: 12600886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destabilizing role of cathepsin S in murine atherosclerotic plaques.
    Rodgers KJ; Watkins DJ; Miller AL; Chan PY; Karanam S; Brissette WH; Long CJ; Jackson CL
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):851-6. PubMed ID: 16410454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rd1 Mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C.
    Ahuja S; Ahuja-Jensen P; Johnson LE; Caffé AR; Abrahamson M; Ekström PA; van Veen T
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1089-96. PubMed ID: 18326735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of thiol proteases in tissue injury and remodeling.
    Chapman HA; Munger JS; Shi GP
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S155-9. PubMed ID: 7952652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.
    Sukhova GK; Zhang Y; Pan JH; Wada Y; Yamamoto T; Naito M; Kodama T; Tsimikas S; Witztum JL; Lu ML; Sakara Y; Chin MT; Libby P; Shi GP
    J Clin Invest; 2003 Mar; 111(6):897-906. PubMed ID: 12639996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.
    Suganuma E; Babaev VR; Motojima M; Zuo Y; Ayabe N; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V
    J Am Soc Nephrol; 2007 Aug; 18(8):2311-9. PubMed ID: 17634441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.